Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf semaglutide is causing troublesome side effects, the evidence-based approach is to work with your prescriber rather than act unilaterally. Clinical trial data from STEP 1, published in the New England Journal of Medicine, show that most gastrointestinal effects are dose-dependent and time-limited, which means the way you counteract semaglutide's unwanted effects is usually to slow the titration schedule, adjust how and when you take it, or pause treatment under clinical guidance. These are prescription-only medicines; any change to your dose or schedule should go through the clinician who prescribed them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors in the gut and brain, slowing gastric emptying and reducing appetite. That same mechanism is the direct cause of the most common side effects: nausea, vomiting, diarrhoea, constipation, indigestion, and burping. The STEP 1 trial found these effects were most pronounced shortly after a dose increase and typically settled within a fortnight. That pattern is not incidental; it is why the licensed titration schedule exists. Starting at 0.25 mg and moving upward in monthly steps gives the gut time to adapt.
The NHS semaglutide medicines page is the most reliable plain-English source on what to expect at each stage, and it distinguishes clearly between effects that pass on their own and symptoms that warrant urgent attention. Severe, persistent stomach pain that extends into the back should be assessed by a doctor promptly; this is the warning pattern associated with pancreatitis, flagged by the MHRA in its January 2026 Drug Safety Update. Read it in context on our semaglutide information page.
Weight regain after stopping is also evidence-based, not anecdotal. Because semaglutide acts pharmacologically rather than permanently re-setting appetite biology, appetite tends to return when the medicine is withdrawn. STEP 1 follow-up data showed meaningful weight regain within a year of stopping. That is not a reason to stay on treatment indefinitely against your wishes; it is a reason to plan the transition carefully with your prescriber.
Slowing gastric emptying is the mechanism and the problem simultaneously. Several practical adjustments work with that physiology rather than against it. Eat smaller portions at each sitting; a stomach that empties slowly needs less in it to feel full, and overfilling it is the most reliable trigger for nausea. Favour lower-fat meals during the first weeks at any new dose, since fat slows emptying further. Eat slowly and stop before you feel full. Keep meals at consistent times where you can; erratic eating patterns seem to worsen nausea for many people on GLP-1 treatment.
Hydration matters more than most people realise. Diarrhoea and vomiting can deplete fluids quickly, and dehydration then compounds fatigue and headache. Sip water steadily through the day rather than drinking large amounts at once. If you are having a week of particularly poor tolerance, for instance because you are ill with something unrelated, contact your prescriber rather than quietly reducing your own dose. The Wegovy treatment overview covers the injection schedule in full, including how a prescriber typically handles dose pauses.
Timing of your weekly injection can make a difference too. Some people find injecting on a day when they can rest the following morning more manageable. If a Friday injection means a quieter Saturday, and a Monday injection lands around a busy work week or a payday social calendar, your prescriber can note your preference. That kind of small adjustment costs nothing and is worth raising.
Stopping abruptly is possible but not usually the approach clinical guidance recommends. A planned wind-down, stepping back through lower doses before discontinuing, gives your metabolism more time to adjust and tends to produce slower, more manageable appetite return. Your prescriber can outline what that looks like for your current dose.
Lifestyle behaviours that supported weight loss during treatment matter even more after stopping. Protein intake, adequate sleep, regular physical activity, and structured meal patterns all help to moderate appetite signals when semaglutide is no longer reducing them pharmacologically. The cost and access page for Wegovy includes context on how long treatment typically runs and what people weigh up when deciding to continue or stop.
For anyone reconsidering treatment because of unresolved side effects rather than because they are ready to stop, it is worth looking at whether tirzepatide, which works through a different dual-receptor mechanism, might suit them better. That is a clinical conversation, not a self-referral decision. Our weight-loss treatments overview compares the options available through a registered prescriber.
Slower gastric emptying means any oral medicine taken alongside semaglutide may be absorbed differently. Oral contraceptives are a practical example: the NHS recommends discussing your contraceptive method with your prescriber when starting treatment. For a detailed look at which drug classes are most relevant, our page on semaglutide drug interactions covers the evidence, and the Wegovy-specific interactions page goes further into clinical detail.
Anyone sourcing semaglutide from unverified sellers should be aware that counterfeit products carry an entirely different set of risks. Our page on counterfeit semaglutide covers the MHRA's enforcement activity and how to spot genuine supply. The short version: a prescription from a GPhC-registered pharmacy is the only safe route, and semaglutide is not available over the counter.
If you are dealing with a side effect that is not settling, or if you are unsure whether what you are experiencing is expected, our prescribers are available seven days a week for aftercare support. Speak to our prescribers through a free consultation and get a clinical view specific to your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.